Molecular Biology Companies in BioPortfolio's Corporate Database 
Molecular Biology company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Molecular Biology companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Molecular Biology Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Molecular Biology Companies.
More Information about Molecular Biology on BioPortfolio
We have published hundreds of Molecular Biology news stories on BioPortfolio along with dozens of Molecular Biology Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Molecular Biology for you to read.
Showing "molecular biology" Companies 1 to 25 of 1,200+
Ambry Genetics is a CAP-accredited, CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new...
Auxogyn – Advancing women’s reproductive health through novel scientific and clinical knowledge of early human developmental biology auxology (from Greek αὔξω, auxō, or αὐξάνω, auxanō, "growth") is a meta-term covering the study of human growth and biology gynaecology or gynecology (from Greek gynaikos meaning woman) is the medical...
Chronix Biomedical is a molecular diagnostics company developing blood tests primarily for cancer, including companion diagnostics and tests for detecting minimal residual disease. Chronix is scaling up to offer its pioneering tests through its own laboratories under CLIA certification in North America and the CE mark in Europe. The Companyâs initial...
Foundation Medicine is dedicated to the development of comprehensive tests that will help physicians personalize cancer treatment for their patients. Foundation Medicineâs laboratory tests are designed to accommodate and assimilate a dynamic landscape of cancer genome and other molecular information and growing availability of treatment options. These...
Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of lic...
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi; a discovery that enables the creation of a broad new class of human therapeutics. Using RNAi, Alnylam has built a product platform to develop a deep pipeline of drug products to treat a wide array of important di...
With the advent of new technologies, in the last four years, DNA sequencing has gone through a technological revolution which has completely changed the market. While in 2007 it still cost over 10 million euros to sequence a complete human genome (the first sequencing cost 3 billion dollars in 2003), in 2012 it cost only $4000 for complete sequencing - and very soon it will be possible to sequen...
LI-COR Biosciences is a leader in the design, manufacture, and marketing of integrated instrument systems for plant biology, biotechnology, drug discovery, and environmental research. LI-COR instruments for photosynthesis, carbon dioxide analysis, and light measurement are recognized world wide for standard-setting innovation in plant science research and environmental monitoring.The company pione...
Certara is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara unites Tripos (www.tripos.com) and Pharsight Corporation (www.pharsight.com). Tripos provides innovative scie...
GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients and is focused on developing and commercializing its eSensor detection technology. GenMarkâs XT-8 System is designed to support a broad range of molecular diagnostic te...
Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development...
Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta are discovering and developing novel inhibitors designed for use against the hepatitis C virus, or HCV. These inhibitors include members of the direct acting antivi...
Founded in 2010 in Barcelona, STAT-Diagnostica is focused on the development of Near Patient Testing solutions where fast and accurate diagnostic results are needed. Its in vitro diagnostic system is a versatile, easy-to-use platform that consolidates molecular and immunoassay techniques in a single device.
Microbia is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Microbia is committed to delivering new medicines into important markets with the goal of making a significant difference in patients’ lives. We create and advance innovative therapeutic agents by combining our unique R&D model of highly integrated pharmacology, chemistry, and biology...
Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals, Inc. is focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose, treat and manage disease. The company's two lead compounds, Zemivaâ„¢ and Azedraâ„¢, are in advancing clinical programs. Molecular Insight has completed a Phase 2b clinical trial for its lead cardio...
Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers. Such agents are derived from the sophisticated mutation and selection of Shiga-like toxin (SLT) variants using recombinant DNA...
Symbollon is a specialty pharmaceutical company focused on the development and commercialization of proprietary drugs based on its I2 technology. I2 is the chemical symbol for molecular iodine. Molecular iodine is the active species of iodine, a proven fast acting, broad-spectrum antimicrobial and therapeutic. Formed in 1986, Symbollon completed its initial public offering in December 1993. Since...
CSI Laboratories is a specialized cancer diagnostic laboratory focused specifically on meeting the unique needs and challenges of pathologists and community hospitals. The company provides diagnostic testing in flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization (FISH), immunohistochemistry, molecular genetics and consultations in the...
The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine research in the fields of cell biology, molecular biology, biochemistry, and pre-clinical and clinical drug development. The ISICR provides a forum for sharing knowledge and encourages...
Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMBâs technology provides a safe, rapid and economical alternative for vaccine production. The Center conducts research in the area of plant bi...
KTYHERA Biopharmaceuticals, Inc.
KYTHERA is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market. The aesthetic market is characterized by an aging population, increasing discretionary income and an evolution of patient preference towards care that focuses on quality o...
MolecularImaging.net hosts Molecular Imaging's eNewsletter, quarterly magazine, special sections and portals. The site engages molecular imaging physicians and executives with the latest news and information relating to the fields of molecular imaging and nuclear medicine. MolecularImaging.net is read by physicians, executives and clinicians in molecular i...
HemoShear LLC is a biotechnology research company that combines its scientific expertise with its unique technology in partnership with pharmaceutical companies to accelerate drug discovery and development. HemoShear has scientific expertise in the areas of human and animal biology, bioinformatics and molecular profiling for target identification and valid...
Dr. Yie-Hwa Chang founded the Company in August 2001. The Company is commercializing core technologies for which it has secured an exclusive license from Saint Louis University, including the following: (i) Bridge-It®, a DNA-binding protein-based bioassay platform, (ii) a related variant â the molecular PINCER®-based homogeneous biosensor and bi...
ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnolog...
